The Federal Trade Commission alleges that we shared identifiable information about people who visited our website or used our app between July 2017 and April 2020 without their permission. This information included details about drug and health conditions people searched and their prescription medications. We shared this information with third parties, including Facebook. In some cases, GoodRx used the information to target people with health-related ads.

The Federal Trade Commission alleges we broke the law by sharing this health information without users' permission. To resolve the case, we have agreed to an FTC order requiring that:

We'll tell applicable third parties (like Facebook) who received that information to delete it.
We'll never share your health information with applicable third parties (like Facebook) for advertising purposes.
We won't share your health information with applicable third parties (like Facebook) for other purposes, unless we get your permission first.
We'll put in place a comprehensive privacy program with heightened procedures and controls to protect your personal and health information. An independent auditor will review our program to make sure we're protecting your information. These audits will happen every two years for 20 years.

If you have any questions, email us at privacy@goodrx.com.

To learn more about the settlement, go to ftc.gov and search for "GoodRx".

For advice on protecting your health privacy, read the FTC's Does your health app protect your sensitive info?

Neurotrophic Keratitis on GoodRx Health

Browse the full list of articles related to Neurotrophic Keratitis.

Good news for your inbox